Stephanie D. Kraft-Terry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stephanie D. Kraft-Terry has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Howard E. Gendelman
University of Nebraska Medical Center
7 shared publications Pawel Ciborowski
Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska 68198-5880, United States
4 shared publications- Howard S. Fox
Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, USA
2 shared publications Irena Kadiu
Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, USA
2 shared publicationsJianuo Liu
Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, USA
2 shared publications- Linda Chang
Department of Diagnostic Radiology and Nuclear Medicine , University of Maryland School of Medicine , Baltimore , MD , USA
2 shared publications
Latest Publications
- Open Access
- 1 July 2019
- Published by NACADA: The Global Community for Academic Advising Inc. in NACADA Journal
- Vol. 39 (1) , 60-76
Direct Measure Assessment of Learning Outcome–Driven Proactive Advising for Academically At-Risk Students
- 1 July 2019
- Published by NACADA: The Global Community for Academic Advising Inc. in NACADA Journal
- Vol. 39 (1) , 60-76
Open AccessDirect Measure Assessment of Learning Outcome–Driven Proactive Advising for Academically At-Risk Students
- 12 May 2013
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 8 (3) , 576-593
Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain
Proton magnetic resonance spectroscopy (1H MRS) has been applied to numerous clinical studies, especially for neurological disorders. This technique can non-invasively evaluate brain metabolites and neurochemicals in selected brain regions and is particularly useful for assessing neuroinflammatory disorders. Neurometabolites assessed with MRS include the neuronal markers N-acetylaspartate (NAA) and glutamate (Glu), as well as the glial marker myo-inositol (MI). Therefore, the concentrations of these metabolites typically correspond to disease severity and often correlate well with clinical variables in the various brain disorders. Neuroinflammation with activated astrocytes and microglia in brain disorders are often associated with elevated MI, and to a lesser extent elevated total creatine (tCr) and choline containing compounds (Cho), which are found in higher concentrations in glia than neurons, while neuronal injury is indicated by lower than normal levels of NAA and Glu. This review summarizes the neurometabolite abnormalities found in MRS studies performed in patients with neuroinflammatory disorders or neuropathic pain, which also may be associated with neuroinflammation. These brain disorders include multiple sclerosis, neuroviral infections (including Human Immunodeficiency virus and Hepatitis C), degenerative brain disorders (including Alzheimer’s disease and Parkinson’s disease), stimulant abuse (including methamphetamine and cocaine) as well as several chronic pain syndromes.
- 12 May 2013
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 8 (3) , 576-593
Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain
Proton magnetic resonance spectroscopy (1H MRS) has been applied to numerous clinical studies, especially for neurological disorders. This technique can non-invasively evaluate brain metabolites and neurochemicals in selected brain regions and is particularly useful for assessing neuroinflammatory disorders. Neurometabolites assessed with MRS include the neuronal markers N-acetylaspartate (NAA) and glutamate (Glu), as well as the glial marker myo-inositol (MI). Therefore, the concentrations of these metabolites typically correspond to disease severity and often correlate well with clinical variables in the various brain disorders. Neuroinflammation with activated astrocytes and microglia in brain disorders are often associated with elevated MI, and to a lesser extent elevated total creatine (tCr) and choline containing compounds (Cho), which are found in higher concentrations in glia than neurons, while neuronal injury is indicated by lower than normal levels of NAA and Glu. This review summarizes the neurometabolite abnormalities found in MRS studies performed in patients with neuroinflammatory disorders or neuropathic pain, which also may be associated with neuroinflammation. These brain disorders include multiple sclerosis, neuroviral infections (including Human Immunodeficiency virus and Hepatitis C), degenerative brain disorders (including Alzheimer’s disease and Parkinson’s disease), stimulant abuse (including methamphetamine and cocaine) as well as several chronic pain syndromes.
- 1 June 2012
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 18 (4) , 291-302
Neuroimaging studies of the aging HIV-1-infected brain
Highly active antiretroviral therapy (HAART) has increased life expectancy among HIV-infected individuals, and by 2015, at least half of all HIV-infected individuals will be over 50 years of age. Neurodegenerative processes associated with aging may be facilitated by HIV-1 infection, resulting in premature brain aging. This review will highlight brain abnormalities in HIV patients in the setting of aging, focusing on recent neuroimaging studies of the structural, physiological, functional and neurochemical changes. Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy studies performed during the pre-HAART era or on antiretroviral-naive subjects suggest an accelerated aging process, while those on HAART-treated subjects suggest premature brain atrophy. Diffusion tensor imaging studies yielded conflicting findings on the relationship between HIV and age in neuroasymptomatic individuals. Functional MRI studies found evidence of premature or accelerated aging processes in the brains of HIV subjects. Lastly, many age-related illnesses such as diabetes, stroke, and depression, as well as comorbid substance abuse, may further exacerbate the aging process in the HIV-infected brain, leading to premature or accelerated age-related brain changes. Given the different pathologic or physiologic changes in the brain assessed by the different neuroimaging techniques, using a multimodal approach in longitudinal follow-up studies is recommended for future studies.
- 1 June 2012
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 18 (4) , 291-302
Neuroimaging studies of the aging HIV-1-infected brain
Highly active antiretroviral therapy (HAART) has increased life expectancy among HIV-infected individuals, and by 2015, at least half of all HIV-infected individuals will be over 50 years of age. Neurodegenerative processes associated with aging may be facilitated by HIV-1 infection, resulting in premature brain aging. This review will highlight brain abnormalities in HIV patients in the setting of aging, focusing on recent neuroimaging studies of the structural, physiological, functional and neurochemical changes. Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy studies performed during the pre-HAART era or on antiretroviral-naive subjects suggest an accelerated aging process, while those on HAART-treated subjects suggest premature brain atrophy. Diffusion tensor imaging studies yielded conflicting findings on the relationship between HIV and age in neuroasymptomatic individuals. Functional MRI studies found evidence of premature or accelerated aging processes in the brains of HIV subjects. Lastly, many age-related illnesses such as diabetes, stroke, and depression, as well as comorbid substance abuse, may further exacerbate the aging process in the HIV-infected brain, leading to premature or accelerated age-related brain changes. Given the different pathologic or physiologic changes in the brain assessed by the different neuroimaging techniques, using a multimodal approach in longitudinal follow-up studies is recommended for future studies.
- Open Access
- 3 May 2011
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 10 (6) , 2852-2862
Pulsed Stable Isotope Labeling of Amino Acids in Cell Culture Uncovers the Dynamic Interactions between HIV-1 and the Monocyte-Derived Macrophage
Dynamic interactions between human immunodeficiency virus-1 (HIV-1) and the macrophage govern the tempo of viral dissemination and replication in its human host. HIV-1 affects macrophage phenotype, and the macrophage, in turn, can modulate the viral life cycle. While these processes are linked to host–cell function and survival, the precise intracellular pathways involved are incompletely understood. To elucidate such dynamic virus–cell events, we employed pulsed stable isotope labeling of amino acids in cell culture. Alterations in de novo protein synthesis of HIV-1 infected human monocyte-derived macrophages (MDM) were examined after 3, 5, and 7 days of viral infection. Synthesis rates of cellular metabolic, regulatory, and DNA packaging activities were decreased, whereas, those affecting antigen presentation (major histocompatibility complex I and II) and interferon-induced antiviral activities were increased. Interestingly, enrichment of proteins linked to chromatin assembly or disassembly, DNA packaging, and nucleosome assembly were identified that paralleled virus-induced cytopathology and replication. We conclude that HIV-1 regulates a range of host MDM proteins that affect its survival and abilities to contain infection.
- 3 May 2011
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 10 (6) , 2852-2862
Open AccessPulsed Stable Isotope Labeling of Amino Acids in Cell Culture Uncovers the Dynamic Interactions between HIV-1 and the Monocyte-Derived Macrophage
Dynamic interactions between human immunodeficiency virus-1 (HIV-1) and the macrophage govern the tempo of viral dissemination and replication in its human host. HIV-1 affects macrophage phenotype, and the macrophage, in turn, can modulate the viral life cycle. While these processes are linked to host–cell function and survival, the precise intracellular pathways involved are incompletely understood. To elucidate such dynamic virus–cell events, we employed pulsed stable isotope labeling of amino acids in cell culture. Alterations in de novo protein synthesis of HIV-1 infected human monocyte-derived macrophages (MDM) were examined after 3, 5, and 7 days of viral infection. Synthesis rates of cellular metabolic, regulatory, and DNA packaging activities were decreased, whereas, those affecting antigen presentation (major histocompatibility complex I and II) and interferon-induced antiviral activities were increased. Interestingly, enrichment of proteins linked to chromatin assembly or disassembly, DNA packaging, and nucleosome assembly were identified that paralleled virus-induced cytopathology and replication. We conclude that HIV-1 regulates a range of host MDM proteins that affect its survival and abilities to contain infection.
- 1 January 2011
- Published by Elsevier in Cellular Immunology
- Vol. 271 (2) , 239-255
Proteomic biosignatures for monocyte–macrophage differentiation
- 1 January 2011
- Published by Elsevier in Cellular Immunology
- Vol. 271 (2) , 239-255
Proteomic biosignatures for monocyte–macrophage differentiation
- Open Access
- 5 November 2010
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 4 (10-11) , 879
Erratum: Proteomic analyses of monocytes obtained from Hispanic women with HIV‐associated dementia show depressed antioxidants
- 5 November 2010
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 4 (10-11) , 879
Open AccessErratum: Proteomic analyses of monocytes obtained from Hispanic women with HIV‐associated dementia show depressed antioxidants
- Open Access
- 13 July 2010
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 4 (8-9) , 706-714
Proteomic analyses of monocytes obtained from Hispanic women with HIV‐associated dementia show depressed antioxidants
Purpose : Monocyte ingress into the brain during progressive human immunodeficiency virus (HIV‐1) infection parallels the severity of cognitive impairments. Although activated monocyte phenotypes emerge in disease, the functional correlates of these cells remain unresolved. Experimental design : To this end, we studied the proteome of blood‐derived monocytes obtained from Hispanic women with the most severe form of HIV‐associated neurocognitive disorders, HIV‐associated dementia (HAD). Monocytes isolated from peripheral blood mononuclear cells by CD14+ immunoaffinity column chromatography were >95% pure. Cells were recovered from four patients without evidence of cognitive impairment and five with HAD and analyzed by 2‐D DIGE and tandem MS. Results : Importantly, ADP ribosylhydrolase, myeloperoxidase, thioredoxin, peroxiredoxin 3, NADPH, and GTPase‐activating protein were all downregulated in HAD. In regards to myeloperoxidase, thioredoxin, and peroxiredoxin 3, these changes were validated in an additional cohort of 30 patients by flow cytometry. Conclusions and clinical relevance : We conclude that deficits in monocyte antioxidants lead to neuronal damage through the loss of hydrogen peroxide scavenging capabilities; thus exposing neurons to apoptosis‐inducing factors. Altered monocyte functions therefore may contribute to the development and progression of cognitive impairment.
- 13 July 2010
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 4 (8-9) , 706-714
Open AccessProteomic analyses of monocytes obtained from Hispanic women with HIV‐associated dementia show depressed antioxidants
Purpose : Monocyte ingress into the brain during progressive human immunodeficiency virus (HIV‐1) infection parallels the severity of cognitive impairments. Although activated monocyte phenotypes emerge in disease, the functional correlates of these cells remain unresolved. Experimental design : To this end, we studied the proteome of blood‐derived monocytes obtained from Hispanic women with the most severe form of HIV‐associated neurocognitive disorders, HIV‐associated dementia (HAD). Monocytes isolated from peripheral blood mononuclear cells by CD14+ immunoaffinity column chromatography were >95% pure. Cells were recovered from four patients without evidence of cognitive impairment and five with HAD and analyzed by 2‐D DIGE and tandem MS. Results : Importantly, ADP ribosylhydrolase, myeloperoxidase, thioredoxin, peroxiredoxin 3, NADPH, and GTPase‐activating protein were all downregulated in HAD. In regards to myeloperoxidase, thioredoxin, and peroxiredoxin 3, these changes were validated in an additional cohort of 30 patients by flow cytometry. Conclusions and clinical relevance : We conclude that deficits in monocyte antioxidants lead to neuronal damage through the loss of hydrogen peroxide scavenging capabilities; thus exposing neurons to apoptosis‐inducing factors. Altered monocyte functions therefore may contribute to the development and progression of cognitive impairment.
- 1 March 2010
- Published by Elsevier in Neurobiology of Disease
- Vol. 37 (3) , 542-548
HIV-1 neuroimmunity in the era of antiretroviral therapy
- 1 March 2010
- Published by Elsevier in Neurobiology of Disease
- Vol. 37 (3) , 542-548
HIV-1 neuroimmunity in the era of antiretroviral therapy
- 28 June 2008
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 3 (3) , 173-186
HIV-1-Infected Astrocytes and the Microglial Proteome
- 28 June 2008
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 3 (3) , 173-186
HIV-1-Infected Astrocytes and the Microglial Proteome